WA
ORIAW

Whitebox Advisors’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Whitebox Advisors’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,000
Closed -$1.2K – 570
2023
Q1 		$1.2K Hold
15,000
– – ﹤0.01% 540
2022
Q4 		$2.28K Hold
15,000
– – ﹤0.01% 626
2022
Q3 		$2K Hold
15,000
– – ﹤0.01% 865
2022
Q2 		$2K Hold
15,000
– – ﹤0.01% 875
2022
Q1 		$6K Hold
15,000
– – ﹤0.01% 892
2021
Q4 		$14K Buy
+15,000
New +$15.7K ﹤0.01% 773

Whitebox Advisors's ORIAW Position: Q2 2023 in Review

Whitebox Advisors sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 15,000 shares — an estimated $1.2K sold.

Whitebox Advisors first reported a position in ORIAW in Q4 2021 and held it in 6 quarters. The position peaked at $14K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

  • Whitebox Advisors reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Whitebox Advisors sold 15,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $1.2K.
  • Whitebox Advisors first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and held it in 6 quarters.
  • Whitebox Advisors's Orion Biotech Opportunities Corp. Warrant position peaked at $14K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.